Navigation Links
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
Date:7/1/2009

ntigens licensed from its collaborative partners.

About Morphotek

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, is a biopharmaceutical company specializing in the development of protein and antibody products through the use of novel and proprietary technologies. These technologies have been successfully applied to a variety of molecules that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications. The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. For more information, please visit www.morphotek.com.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd., and supports the activities of its operating companies in North America, which include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical Research Inc., a clinical development group; Eisai Inc., a commercial operation with manufacturing and marketing/sales functions; and Eisai Machinery U.S.A., which markets and maintains pharmaceutical manufacturing machinery.

About Synageva

Synageva BioPharma Corporation is a biopharmaceutical company dedicated to developing and commercializing novel, next generation, and follow-on protein therapeutics that leverage the unique competitive advantages of its proprietary Synageva Expression Platform (SEP(TM)). Synageva's development programs address specific unme
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
2. Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
3. Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...Nov. 5 Cepheid (Nasdaq: ...e speaking at the following investor conferences, ..., , Credit Suisse Healthcare Confe...ovember, 2009 at 10 a.m. Mountain Time, ...ngland, Tuesday, 1 December, 2009 ...
(Date:11/5/2009)...G, Pa., Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP ...ne" or the "Company") today announced,that the Com... results on,Monday, November 9, 2009, after the ma...nference call at 5:00 pm ET on November 9, 2009,to...y access the call by,dialing 1-888-713-4211 or 1-6...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must be stopped...ure film "A Call to Arms:2009 Edition" a... Immunity: The Human Anthrax Vaccine Story" t...nger of top secret government science turned into ...bility to its victims. It is available for world-...
(Date:11/4/2009)... Nov. 4 Nektar Therapeut...results for the third quarter ended September 30, ...ber 30, 2009 improved to $31.0 million or $0.33 pe...n or $0.40 per share in the third quarter of 2008.... its operating efficiencies as compared to a year ...
Breaking Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...uly 10 , - 1st Half-Year Sales Up 16%, - Revisi... than or equal,to)12%, EUR millions ... EURM %Sales EURM %Sales ... change change Sou... 26.8 71 15 Other EU countries (2) 6.9 ...
...ly 10 Quest Diagnostics,Incorporated (NYSE: DGX ...ing, information and services, announced today tha...lic on Tuesday, July 22, before the market,opens, ...l with investors,to discuss the results beginning ...ss the conference call through a live audio webcas...
...0 /PRNewswire-FirstCall/ - Angiotech Pharmaceutica...alty pharmaceutical and,medical device company, an...nited Kingdom, the House of Lords, confirmed in a ...Angiotech,s patents related to its,paclitaxel sten...mented,"The decision represents a significant deve...
Other Biology Technology:Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth 2Quest Diagnostics to Release Second Quarter 2008 Financial Results 2Angiotech wins before the UK House of Lords 2Angiotech wins before the UK House of Lords 3Angiotech wins before the UK House of Lords 4
(Date:11/4/2009)...that deciphered the DNA codes, or genomes, of the ... joined The Genome 10K Project, an international e...uences on 10,000 species of animals for conducting... not be achieved. , Participating in The Genome ... Nov. 5, 2009 issue of the Journal of Heredity , ...
(Date:11/4/2009)...20 Aware, Inc. (Nasdaq: ...y and biometrics software, today reported financia...0, 2009. ,, Michael Tzannes, Aware,s Chairman..., we announced an agreement to sell our DSL and ho...ss semiconductor company being spun out of Infineo...
(Date:11/4/2009)...tists at the University of North Carolina at Chape...lifornia, San Francisco have developed and experim...iseases for existing drugs. , The researchers de...imilar the structures of all known drugs are to th... ligands -- of disease targets within the cell. In...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Study points to new uses, unexpected side effects of already existing drugs 2US Farms Inc Announces Distribution Partnership With Natures Best 58507 1US Farms Inc Announces Distribution Partnership With Natures Best 58507 2US Farms Inc Announces Distribution Partnership With Natures Best 58507 3Penn Study Asks Protection or Peril 3F Gun Possession of Questionable Value in an Assault 58505 1Penn Study Asks Protection or Peril 3F Gun Possession of Questionable Value in an Assault 58505 2Penn Study Asks Protection or Peril 3F Gun Possession of Questionable Value in an Assault 58505 3Global Biofuels Growth to Double by 2015 14289 1Global Biofuels Growth to Double by 2015 14289 2Global Biofuels Growth to Double by 2015 14289 3Global Biofuels Growth to Double by 2015 14289 4
...Leicester has proposed an immense (1.5km) exhibiti...nd to give a vivid perspective of how quickly huma...accumulate on deep ocean floors at a rate of a few...is called stratigraphy involves drilling vertica... which gives a picture of continually changing lif...
...iversity and the University of California have bee...derwater noise on an unusual whale species and hav...head and ears. , Advances in Finite Element Model...computer processing have made it possible to simul...d whale when a sonar signal is sent out or receive...
...our geometry homework, and for scientists seeking ...zheimers, this advice turns out to be right on the...s, shape determines the all-important function of ...in molecule responsible for Parkinsons binds with ...rupt this interaction -- preventing disease progre...
Other Biology News:How is that whale listening? 2It's all about geometry: Protein contact surfaces hold key to cures 2It's all about geometry: Protein contact surfaces hold key to cures 3
...Microdissection , CapSure HS and CapSure Macro LC...populations of pure cells from tissue sections and...on., Ensure the Integrity of Microdissected Cell... LCM Caps have a patented transfer film bonded to ...
...Microdissection , CapSure HS and CapSure Macro LC...populations of pure cells from tissue sections and...on., Ensure the Integrity of Microdissected Cell... LCM Caps have a patented transfer film bonded to ...
...CM) is the method of choice for thousands of resea...nly instrument to offer both LCM and Laser Cutting...r Cutting provides unprecedented speed and precis...arge numbers of cells. , LCM is a gentle techn...
Hybridizer (220 V) from Dako
Biology Products: